𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase I/II study of adoptive transfer of γδ T cells in combination with zoledronic acid and IL-2 to patients with advanced renal cell carcinoma

✍ Scribed by Hirohito Kobayashi; Yoshimasa Tanaka; Junji Yagi; Nagahiro Minato; Kazunari Tanabe

Publisher
Springer-Verlag
Year
2011
Tongue
English
Weight
674 KB
Volume
60
Category
Article
ISSN
0340-7004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I trial of interferon α2b and lipo
Phase I trial of interferon α2b and liposome-encapsulated all-trans retinoic acid in the treatment of patients with advanced renal cell carcinoma
✍ Jonathan S. Goldberg; Manuel Vargas; Alyssa S. Rosmarin; Matthew I. Milowsky; Ni 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 317 KB

## Abstract ## BACKGROUND Studies suggest that retinoic acid (RA) can augment the antitumor effects of interferon‐based therapy in patients with advanced renal cell carcinoma (RC); however, this benefit has not been achieved convincingly using oral formulations of 13‐cis RA and all‐__trans__ RA. L

Interferon-α-2a with or without 13-cis r
Interferon-α-2a with or without 13-cis retinoic acid in patients with progressive, measurable metastatic renal cell carcinoma : Results of a randomized Phase II study (European Organization for Research and Treatment of Cancer Study 30951)
✍ Sophie D. Fosså; Gerald H. J. Mickisch; Pieter H. M. De Mulder; Simon Horenblas; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB

## Background: In patients with metastatic renal cell carcinoma (mrcc), interferon-alpha (ifn) monotherapy leads to response rates of 5-15%, dependent on the selection of patients. in 1995, preclinical and clinical data indicated an improvement of these results if ifn was combined with 13-cis retin